Selected article for: "case infection time and infection time"

Author: De Francesco, Maria A.; Alberici, Federico; Bossini, Nicola; Scolari, Francesco; Pascucci, Federico; Tomasoni, Gabriele; Caruso, Arnaldo
Title: Pneumocystis jirevocii and SARS-CoV-2 Co-Infection: A Common Feature in Transplant Recipients?
  • Cord-id: b01o6f69
  • Document date: 2020_9_18
  • ID: b01o6f69
    Snippet: COVID-19 might potentially give rise to a more severe infection in solid organ transplant recipients due to their chronic immunosuppression. These patients are at a higher risk of developing concurrent or secondary bacterial and fungal infections. Co-infections can increase systemic inflammation influencing the prognosis and the severity of the disease, and can in turn lead to an increased need of mechanical ventilation, antibiotic therapy and to a higher mortality. Here we describe, for the fir
    Document: COVID-19 might potentially give rise to a more severe infection in solid organ transplant recipients due to their chronic immunosuppression. These patients are at a higher risk of developing concurrent or secondary bacterial and fungal infections. Co-infections can increase systemic inflammation influencing the prognosis and the severity of the disease, and can in turn lead to an increased need of mechanical ventilation, antibiotic therapy and to a higher mortality. Here we describe, for the first time in Europe, a fatal case of co-infection between SARS-CoV-2 and Pneumocystis jirevocii in a kidney transplant recipient.

    Search related documents:
    Co phrase search for related documents
    • abnormal coagulation and acute kidney injury: 1, 2, 3
    • abnormal coagulation and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • abnormal coagulation and lung damage: 1
    • abnormal coagulation and lymphocyte count: 1, 2
    • acute ards respiratory distress syndrome and local protocol: 1, 2, 3
    • acute ards respiratory distress syndrome and low lymphocyte count: 1, 2
    • acute ards respiratory distress syndrome and low number: 1
    • acute ards respiratory distress syndrome and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • acute ards respiratory distress syndrome and lung inflammatory response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • acute ards respiratory distress syndrome and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
    • acute ards respiratory distress syndrome and lymphocyte subpopulation: 1
    • acute kidney injury and local protocol: 1, 2, 3
    • acute kidney injury and low lymphocyte count: 1
    • acute kidney injury and low number: 1
    • acute kidney injury and lung damage: 1, 2, 3, 4, 5, 6
    • acute kidney injury and lung inflammatory response: 1, 2
    • acute kidney injury and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
    • acute sars cov respiratory syndrome coronavirus and local protocol: 1, 2, 3
    • acute sars cov respiratory syndrome coronavirus and low lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11